Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart failure, particularly among ...
A high-resolution, motion-resolved MRI method provides rapid and reliable measurement of heart oxygen consumption ...
Eugene Braunwald, who was widely recognized as “ The Father of Modern Cardiology ,” died on April 22 at the age of 96. When I ...
The ACACIA-HCM trial met both primary endpoints, potentially opening treatment to a new population of heart disease patients ...
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver disease and GI oncological therapeutics, today announced a ...
When Malachy Nixon, 40, began experiencing mild chest pains and breathlessness, he dismissed them as anxiety or declining ...
Myqorzo’s success in “non-obstructive” hypertrophic cardiomyopathy separates it from Bristol Myers Squibb’s rival Camzyos and ...
Hedge Ratio probably raised more questions than he answered with an impressive win in a $100,000 optional claimer in his ...
Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has awarded a Commissioner's National Priority ...
Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults 1. Adjuvanted influenza vaccines did not differ significantly ...
Georgina, known as Gina, says a quick and free test at Everton in the Community’s BEAT Breathlessness Hub “saved” her life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results